Top compounds associated with response to TAS2R30


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.5
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC 0.048 0.5
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.5
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.019 0.5
mRNA JW-480 CTRPv2 pan-cancer AAC -0.023 0.5
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.022 0.5
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.021 0.5
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.021 0.5
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.5
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.019 0.6
Download CSV